In allergic mouse models of food allergies, IgETRAP, a novel drug targeting IgE, demonstrated enhanced suppression of mast cell degranulation and allergy symptoms when administered alongside anti-allergy probiotics, without the need for dose escalation [5]. Here, IGHE is linked to allergic disease.